Biotech 2050 Podcast
61. Groundbreaking immunology microbe oral therapies, Simba Gill, CEO, Evelo Biosciences
over 3 years ago
60. BIOS Edition: Investing in biotech and healthcare, Yizhen Dong, Partner, Global Founders Capital
over 3 years ago
59. Targeted cancer therapies using engineered viruses, Alice Bexon, Chief Medical Officer, Vyriad
over 3 years ago
57. Next frontier in schizophrenia and mental health, Andrew Miller, Founder and COO, Karuna
over 3 years ago
56. Turning cancer on itself, Sam Mazin, Founder and CTO, Thorsten Melcher, CBO, RefleXion
over 3 years ago
55. Gene therapy for hearing loss, Heather Wolff, VP of Clinical Development Operations, Decibel
over 3 years ago
54. CRISPR treating cancer, Rachel Haurwitz, Co-founder and CEO, Caribou Biosciences
over 4 years ago